Status:
RECRUITING
Photoacoustic/Ultrasound Imaging for Breast Nodule Diagnosis, Molecular Classification, and Neoadjuvant Chemotherapy Response Evaluation
Lead Sponsor:
Peking Union Medical College Hospital
Conditions:
Breast Masses
Breast Cancer
Eligibility:
FEMALE
18+ years
Phase:
NA
Brief Summary
Photoacoustic (PA) imaging (PAI) emergerd as a rapidly evolving biomedical imaging modality, which combines the merits of optical imaging and ultrasound (US) imaging, and has a capacity in morphologic...
Detailed Description
The multi-modality PA/US imaging system was built on a high-end commercial US platform and allowed real-time imaging of grey-scale US imaging, Color-Doppler US (CDUS) imaging and dual-wavelength PAI. ...
Eligibility Criteria
Inclusion
- The patients were above 18 years-old;
- The patients were presented with a breast tumor, which were clearly shown on routine ultrasound; Biopsy or surgery of breast lesions was performed within 1 week and pathological diagnosis was obtained.
- Patients agreed to participate in this experiment and signed the Subject Informed Consent.
Exclusion
- Pregnant or lactating women;
- Breast inflammation or local external injury;
- The breast mass has been excised for biopsy.
- Poor photoacoustic imaging effect.
- Deep lesion location (\>3.5 cm)
Key Trial Info
Start Date :
June 12 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2027
Estimated Enrollment :
500 Patients enrolled
Trial Details
Trial ID
NCT06908291
Start Date
June 12 2023
End Date
December 31 2027
Last Update
April 3 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Peking Union Medical College Hospital
Beijing, Beijing Municipality, China, 100730